Author Topic: FDA approves Inlyta to treat patients with a type of advanced kidney cancer  (Read 13 times)

recalls-bot

  • Global Moderator
  • Hero Member
  • *****
  • Posts: 1714
FDA approves Inlyta to treat patients with a type of advanced kidney cancer
27 January 2012, 11:09 am

The U.S. Food and Drug Administration today approved Inlyta (axitinib) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer.

Source: Food and Drug Administration--Press Releases


Tags:
 

members